STRESNIL DIN 00755710
Health Canada record
| Active ingredient(s) | AZAPERONE 40 MG |
|---|---|
| Dosage form | Solution |
| Route | Intramuscular |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Veterinary |
| ATC | |
| Original market date | 31-Dec-1988 |
| Current status date | 01-Dec-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27172 | 2021-12-06 | Supplement to a New Drug Submission (SNDS) | Addition of a manufacturing and testing site - drug substance |
| 23659 | 2020-05-21 | Supplement to a New Drug Submission (SNDS) | ADDIITION OF DRUG MANUFACTURING AND TESTING SITE |
| 20335 | 2018-01-16 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 13532 | 2012-07-31 | New Drug Submission (NDS) | Change in ownership |
| 12230 | 2011-03-31 | New Drug Submission (NDS) | Change in ownership |
| 3631 | 2004-05-19 | New Drug Submission (NDS) |
International API supply for AZAPERONE
0 active FDA Drug Master Files.
Request a quote for STRESNIL